An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic

The COVID-19 pandemic resulted in suspending in-person human subject research across most institutions in the US. Our extensive cognitive assessment for a phase-2 clinical trial, Physical Activity and Alzheimer's Disease–2 (PAAD-2), was also paused in March 2020. It was important to identify st...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, K. Shin, Etnier, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249106/
https://www.ncbi.nlm.nih.gov/pubmed/34217888
http://dx.doi.org/10.1016/j.cct.2021.106500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249106/
https://www.ncbi.nlm.nih.gov/pubmed/34217888
http://dx.doi.org/10.1016/j.cct.2021.106500

Ejemplares similares